What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Breast cancer
His primary areas of study are Breast cancer, Internal medicine, Oncology, Cancer and Chemotherapy.
His Breast cancer research integrates issues from Surgery, Retrospective cohort study and Pathology.
His study in Surgery is interdisciplinary in nature, drawing from both Gastroenterology and Metastasis.
His work carried out in the field of Oncology brings together such families of science as Neoadjuvant therapy, Combination chemotherapy, Survival rate, Gynecology and Docetaxel.
The concepts of his Cancer study are interwoven with issues in Stage, Structured interview and Family medicine.
He interconnects Prospective cohort study and Lymph node in the investigation of issues within Chemotherapy.
His most cited work include:
- Neoadjuvant Therapy with Paclitaxel followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy and Concurrent Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: An Update of the Initial Randomized Study Population and Data of Additional Patients Treated with the Same Regimen (388 citations)
- Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks (347 citations)
- High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller (335 citations)
What are the main themes of his work throughout his whole career to date?
Vicente Valero spends much of his time researching Internal medicine, Breast cancer, Oncology, Cancer and Chemotherapy.
His study in Surgery extends to Internal medicine with its themes.
Vicente Valero has included themes like Gastroenterology, Mastectomy and Carcinoma in his Surgery study.
His studies deal with areas such as Cyclophosphamide and Clinical trial, Retrospective cohort study, Pathology as well as Breast cancer.
His research on Oncology also deals with topics like
- Proportional hazards model which connect with Gynecology,
- Anthracycline and related Taxane.
The various areas that Vicente Valero examines in his Cancer study include Cancer research and Cohort.
He most often published in these fields:
- Internal medicine (75.98%)
- Breast cancer (67.89%)
- Oncology (65.93%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (75.98%)
- Oncology (65.93%)
- Breast cancer (67.89%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Oncology, Breast cancer, Cancer and Neoadjuvant therapy.
The Inflammatory breast cancer, Chemotherapy, Clinical trial and Complete response research Vicente Valero does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as In patient, therefore creating a link between diverse domains of science.
Vicente Valero has researched Oncology in several fields, including Trastuzumab, Targeted therapy, Stage, Triple-negative breast cancer and Cohort.
His Breast cancer research integrates issues from Biopsy, Proportional hazards model and Surgical pathology.
The Cancer study combines topics in areas such as Malnutrition, Depression and Hazard ratio.
His Neoadjuvant therapy research is multidisciplinary, incorporating elements of Epithelial–mesenchymal transition, Cancer research, Paclitaxel and Circulating tumor cell.
Between 2018 and 2021, his most popular works were:
- Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. (43 citations)
- Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation. (42 citations)
- Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study (34 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Breast cancer
Vicente Valero mostly deals with Breast cancer, Internal medicine, Oncology, Metastatic breast cancer and Cancer.
His Breast cancer research focuses on Neoadjuvant therapy in particular.
His studies in Neoadjuvant therapy integrate themes in fields like Cancer stem cell, Metastasis and Chemotherapy.
His studies link Gastroenterology with Internal medicine.
His Oncology study integrates concerns from other disciplines, such as Body mass index, Exemestane, Estrogen receptor alpha and Trastuzumab.
His Metastatic breast cancer research incorporates elements of Phenotype, Gene, Genotype, Hormone receptor and Hormone.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
